Biocryst reports inducement grants under nasdaq listing rule 5635(c)(4)

Research triangle park, n.c., june 03, 2025 (globe newswire) -- biocryst pharmaceuticals, inc. (nasdaq: bcrx) today announced that the compensation committee of biocryst's board of directors granted seven newly-hired employees restricted stock units (rsus) covering an aggregate of 47,250 shares of biocryst common stock. the rsus were granted as of june 2, 2025, as inducements material to each employee entering into employment with biocryst. the rsus were granted in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking